Description of venture idea

A credit rating agencies like Moody’s provide third-party assessments of financial institutions. A similar entity for the fusion industry would enable investors to better categorize and price fusion companies.

Andrew Lo was excited about the idea of a ratings and certification company for fusion that dictates for the entire field what are the relevant milestones (the equivalents of Phase 1, Phase 2, and Phase 3 for biotech companies), independently assesses fusion companies to determine whether they have passed a new phase, and generally establishes itself as the authority on ‘quality’ in the fusion sector. Maybe it verifies the DOE Milestone program achievements. Ally Yost confirmed that would be great.

Market needs this venture would address

Third-party, objective, unbiased assessments of fusion investment opportunities for private & public markets

Technical capabilities this venture might leverage

None

Business model

TBD

Team

Andrew Lo Dennis Whyte

Outstanding risks

  • Is there enough of a market for this among private (not to mention public) investors?
  • According to 2023-11-30 Proto Ventures Channel Forum participants, it’s too early for this venture: there is no fusion product to rate yet, it could be a potential drag on the ecosystem, and there is downside risk.

References

2023-10-02 Proto Ventures advisory board meeting